823 studies found for:    Open Studies | "Pancreatic Diseases"
Show Display Options
Rank Status Study
21 Unknown  Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder
Condition: Pancreatic Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: biopsy
22 Recruiting Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca
Condition: Stage IV Pancreatic Cancer
Intervention: Drug: Ascorbic Acid
23 Recruiting Saline Hypertonic in Preschoolers
Condition: Cystic Fibrosis
Interventions: Drug: 7% Hypertonic Saline (HS);   Drug: 0.9% Isotonic Saline (IS)
24 Recruiting Follow-up Study of Complications of Acute Pancreatitis
Conditions: Pancreatitis;   Pancreatic Neoplasms;   Metabolic Diseases;   Hypertension, Portal;   Respiratory Failure;   Quality of Life
Intervention:
25 Unknown  Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis
Condition: Pancreatitis, Acute Necrotizing
Intervention: Drug: Qingyi granules
26 Recruiting Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine;   Drug: Erlotinib
27 Recruiting The Use of Wound Protector in Whipple's Procedure With Intrabiliary Stent
Conditions: Surgical Wound Infection;   Pancreatic Neoplasms
Intervention: Device: Alexis - a wound protector
28 Recruiting Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole
Condition: Pancreatic Cancer
Intervention: Drug: Pimonidazole hydrochloride
29 Recruiting A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: MM-141;   Drug: Placebo;   Drug: Gemcitabine;   Drug: Nab-Paclitaxel
30 Recruiting Cancer pancréatique métastatique 1ière Ligne : FOLFIRINOX +/- LV5FU2 en Entretien et le Firgem
Condition: Metastatic Pancreatic Cancer
Interventions: Drug: FOLFIRINOX;   Drug: LV5FU2;   Drug: FOLFIRI;   Drug: Gemzar
31 Recruiting A Study to Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI
Conditions: Diabetes Mellitus, Type 2;   Exocrine Pancreatic Insufficiency
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: Omacor® (omega-3-acid ethyl esters)
32 Recruiting OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma
Condition: Pancreatic Cancer
Intervention: Drug: oxaliplatin, irinotecan, capecitabine
33 Recruiting Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Duct Cell Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: alisertib;   Drug: gemcitabine
34 Recruiting A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration
Condition: Pancreatic Cysts
Interventions: Drug: Ciprofloxacin;   Other: Placebo (for ciprofloxacin)
35 Not yet recruiting Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study
Conditions: Pancreatic Adenocarcinoma;   Poorly Differentiated Malignant Neoplasm;   Resectable Pancreatic Cancer;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage IIA Pancreatic Cancer;   Stage IIB Pancreatic Cancer;   Stage III Pancreatic Cancer;   Undifferentiated Pancreatic Carcinoma
Interventions: Drug: Irinotecan Hydrochloride;   Drug: Oxaliplatin;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis
36 Recruiting Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition
Conditions: Lung Carcinoma;   Lower Oesophageal Carcinoma;   Pancreatic Carcinoma
Interventions: Procedure: 4D PET-CT Scan;   Other: No intervention
37 Recruiting Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
Conditions: Pancreatic Cyst;   Pancreatic Intraductal Papillary-Mucinous Neoplasm;   Cystadenoma, Mucinous;   Papillary Mucinous Cystadenoma, Borderline Malignancy
Intervention: Procedure: 98% Ethanol & Paclitaxel injection
38 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
39 Unknown  Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease
Conditions: Heart Disease;   Cystic Fibrosis;   Asthma
Interventions: Procedure: Phase contrast flow velocity mapping (PC);   Procedure: Dynamic contrast-enhanced magnetic resonance imaging
40 Recruiting A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Conditions: Patients Must Have Previously Untreated Apparently Resectable Adenocarcinoma;   of the Pancreas.
Intervention: Drug: Paricalcitol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years